Terns Pharmaceuticals elects three directors and ratifies EY as auditor at 2025 annual meeting

Terns Pharmaceuticals, Inc.

Robert Azelby elected with 56.4M votes for, 3.2M withheld.
Hongbo Lu elected with 52.0M votes for, 7.6M withheld.
Heather Turner elected with 58.3M votes for, 1.3M withheld.
Ratification of Ernst & Young as independent auditor for FY2025 passed with 64.8M for, 28.5K against.
No broker non-votes on ratification; two proposals considered at June 11, 2025 meeting.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.